Company / FCF Margin
TELA Bio, Inc. FCF Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-70.9%
FY2025
5-year range
-166.5% / -70.9%
FY2021-FY2025
Trend
+29.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has increased for 6 consecutive years, from -388.3% in FY2019 to -70.9% in FY2025.
Based on SEC 10-K filings.
-70.9% in FY2025 with a 5-year CAGR of +170.6%.
Improved from -105.4% to -70.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +64.3pp
- 5-Year Change
- +170.6pp
- 10-Year Change
- -
Key checks
Key Insights
- TELA Bio, Inc.'s fcf margin has grown for 6 consecutive years.
- In FY2025, fcf margin increased 29.4% year-over-year.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -70.9% | +29.4% |
| FY2024 | -100.5% | +4.7% |
| FY2023 | -105.4% | +22.0% |
| FY2022 | -135.2% | +18.8% |
| FY2021 | -166.5% | +31.1% |
| FY2020 | -241.6% | +37.8% |
| FY2019 | -388.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026